ROCKLAND, Mass.--(BUSINESS WIRE)--Aug. 24, 2006--BioSphere Medical, Inc. (NASDAQ: BSMD) (“BioSphere”), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations, today announced the Company’s sponsorship of a symposium highlighting the technical and clinical aspects of its HepaSphere(TM) Microspheres in the treatment of primary and metastatic liver cancer. This event will take place on Sunday, September 10, 2006 from 13:45 - 14:15 pm local time at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting, which is being held September 9-13 in Rome, Italy. Representatives of BioSphere will also be available throughout the CIRSE conference at Booth #16.
